Education
About Us
Working with TipRanks
Follow Us
Iradimed Corp (IRMD)
:IRMD
Total Valuation
Iradimed has a market cap or net worth of $674.15M. The enterprise value is $652.50M.
Market Cap$674.15M
Enterprise Value$652.50M
Share Statistics
Iradimed has 12,715,072 shares outstanding. The number of shares has decreased by -2.65% in one year.
Shares Outstanding12,715,072
Owned by Insiders―
Owned by Institutions―
Financial Efficiency
Iradimed’s return on equity (ROE) is 0.22 and return on invested capital (ROIC) is 19.34%.
Return on Equity (ROE)0.22
Return on Assets (ROA)0.20
Return on Invested Capital (ROIC)19.34%
Return on Capital Employed (ROCE)0.24
Revenue Per Employee457.76K
Profits Per Employee120.21K
Employee Count160
Asset Turnover0.74
Inventory Turnover1.62
Valuation Ratios
The current PE Ratio of Iradimed is 36.23. Iradimed’s PEG ratio is 3.08.
PE Ratio36.23
PS Ratio0.00
PB Ratio8.03
Price to Fair Value8.03
Price to FCF39.55
Price to Operating Cash Flow27.20
PEG Ratio3.08
Income Statement
In the last 12 months, Iradimed had revenue of 73.24M and earned 19.23M in profits. Earnings per share was 1.52.
Revenue73.24M
Gross Profit56.35M
Operating Income21.96M
Pretax Income24.28M
Net Income19.23M
EBITDA21.96M
Earnings Per Share (EPS)1.52
Cash Flow
In the last 12 months, operating cash flow was 25.62M and capital expenditures -8.82M, giving a free cash flow of 16.81M billion.
Operating Cash Flow25.62M
Free Cash Flow16.81M
Free Cash Flow per Share1.32
Dividends & Yields
Iradimed pays an annual dividend of $0.17, resulting in a dividend yield of 1.16%
Dividend Per Share$0.17
Dividend Yield1.16%
Payout Ratio37.58%
Free Cash Flow Yield―
Earnings Yield―
Stock Price Statistics
Beta0.74
52-Week Price Change29.49%
50-Day Moving Average52.83
200-Day Moving Average51.68
Relative Strength Index (RSI)56.04
Average Volume (3m)36.16K
Important Dates
Iradimed upcoming earnings date is May 5, 2025, TBA Not Confirmed.
Last Earnings DateFeb 13, 2025
Next Earnings DateMay 5, 2025
Ex-Dividend DateFeb 24, 2025
Financial Position
Iradimed as a current ratio of 8.84, with Debt / Equity ratio of 0.18%
Current Ratio8.84
Quick Ratio7.62
Debt to Market Cap<0.01
Net Debt to EBITDA-2.37
Interest Coverage Ratio0.00
Taxes
In the past 12 months, Iradimed has paid 5.04M in taxes.
Income Tax5.04M
Effective Tax Rate0.21
Enterprise Valuation
Iradimed EV to EBITDA ratio is 29.36, with an EV/FCF ratio of 36.59.
EV to Sales8.80
EV to EBITDA29.36
EV to Free Cash Flow36.59
EV to Operating Cash Flow25.16
Balance Sheet
Iradimed has $52.23M in cash and marketable securities with $0.00 in debt, giving a net cash position of -$52.08M billion.
Cash & Marketable Securities$52.23M
Total Debt$0.00
Net Cash-$52.08M
Net Cash Per Share-$4.10
Tangible Book Value Per Share$6.61
Margins
Gross margin is 76.94%, with operating margin of 29.99%, and net profit margin of 26.26%.
Gross Margin76.94%
Operating Margin29.99%
Pretax Margin33.14%
Net Profit Margin26.26%
EBITDA Margin29.99%
EBIT Margin29.99%
Analyst Forecast
The average price target for Iradimed is $71.00, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
Price Target$71.00
Price Target Upside32.22% Upside
Analyst ConsensusModerate Buy
Analyst Count2
Revenue Growth Forecast11.71%
EPS Growth Forecast11.28%